China Universal Asset Management Co., Ltd. Biomarin Pharmaceutical Inc Transaction History

China Universal Asset Management Co., Ltd.

  • $1.05 Billion
  • Q1 2025

A detailed history of China Universal Asset Management Co., Ltd. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 38,640 shares of BMRN stock, worth $2.25 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
38,640
Previous 40,784 5.26%
Holding current value
$2.25 Million
Previous $2.68 Million 1.9%
% of portfolio
0.26%
Previous 0.26%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 29, 2025
SELL
$61.25 - $72.83 $131,320 - $156,147
-2,144 Reduced 5.26%
38,640 $2.73 Million
Q4 2024

Jan 23, 2025
BUY
$61.93 - $70.49 $234,900 - $267,368
3,793 Added 10.25%
40,784 $2.68 Million
Q3 2024

Oct 25, 2024
BUY
$69.02 - $93.84 $987,676 - $1.34 Million
14,310 Added 63.09%
36,991 $2.6 Million
Q2 2024

Jul 19, 2024
SELL
$74.43 - $92.22 $1.04 Million - $1.29 Million
-13,940 Reduced 38.07%
22,681 $1.87 Million
Q1 2024

Apr 29, 2024
BUY
$83.81 - $99.0 $1.21 Million - $1.43 Million
14,465 Added 65.29%
36,621 $3.2 Million
Q4 2023

May 21, 2024
SELL
$76.22 - $98.51 $1.1 Million - $1.42 Million
-14,465 Reduced 39.5%
22,156 $2.14 Million
Q4 2023

Jan 23, 2024
BUY
$76.22 - $98.51 $1.01 Million - $1.31 Million
13,270 Added 149.34%
22,156 $2.14 Million
Q3 2023

May 21, 2024
BUY
$85.07 - $94.48 $201,786 - $224,106
2,372 Added 36.41%
8,886 $786,000
Q3 2023

Oct 30, 2023
BUY
$85.07 - $94.48 $201,786 - $224,106
2,372 Added 36.41%
8,886 $786,000
Q2 2023

May 21, 2024
SELL
$86.68 - $100.3 $5,720 - $6,619
-66 Reduced 1.0%
6,514 $564,000
Q2 2023

Jul 27, 2023
SELL
$86.68 - $100.3 $5,720 - $6,619
-66 Reduced 1.0%
6,514 $565,000
Q1 2023

May 21, 2024
SELL
$87.74 - $117.27 $1.7 Million - $2.27 Million
-19,350 Reduced 74.62%
6,580 $639,000
Q1 2023

Apr 27, 2023
SELL
$87.74 - $117.27 $1.7 Million - $2.27 Million
-19,350 Reduced 74.62%
6,580 $640,000
Q4 2022

May 21, 2024
SELL
$80.93 - $108.63 $865,222 - $1.16 Million
-10,691 Reduced 29.19%
25,930 $2.68 Million
Q4 2022

Jan 31, 2023
SELL
$80.93 - $108.63 $318,702 - $427,784
-3,938 Reduced 13.18%
25,930 $2.68 Million
Q3 2022

Oct 21, 2022
BUY
$82.16 - $96.94 $142,711 - $168,384
1,737 Added 6.17%
29,868 $2.53 Million
Q2 2022

Aug 12, 2022
BUY
$71.48 - $86.85 $1.52 Million - $1.85 Million
21,271 Added 310.07%
28,131 $2.33 Million
Q1 2022

Apr 25, 2022
BUY
$74.28 - $92.69 $509,560 - $635,853
6,860 New
6,860 $529,000

Others Institutions Holding BMRN

# of Institutions
668
Shares Held
185M
Call Options Held
1.25M
Put Options Held
992K
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $10.8B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track China Universal Asset Management Co., Ltd. Portfolio

Follow China Universal Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email